CACT deficiency is a suspected disease in the field of genetic metabolism, with clinical manifestations of complexity and often involving multiple systems. Early identification and standardized diagnosis are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical manifestations, imaging inspections, laboratory tests and pathological biopsies.
The platform can assist in matching a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, significant improvements have been made in many previously difficult-to-treat genetic metabolic diseases. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to the timely schedule of changes in disease.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of the deficiency of CACT in carnivorous/meat-based ketone transcriptase. 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of changes in conditions and treatment effects.